Search research articles
Contact Us
Filters
Showing results (131-140 of 240) with videos related to
Page
of 24
Sort By:
Journal of Clinical Pharmacology
|
February 1, 1995
Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients
S K Gupta, R L Kunka, A Metz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1982
Pharmacokinetics of psychotropic drugs: what can it tell us?
P D Hrdina, L J Hutchinson, Y D Lapierre, et al.
Circulation
|
November 1, 1979
The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations
E G Giardina, J T Bigger, A H Glassman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 1, 1992
Psychobiological methodology
N D Ryan, S Iyengar, J M Perel, et al.
Psychopharmacology Bulletin
|
January 1, 1994
Metabolic and physiologic consequences of nortriptyline treatment in the elderly
B G Pollock, J M Perel, C F Paradis, et al.
The Journal of Clinical Psychiatry
|
March 16, 2005
Weight changes in postpartum women with remitted depression
Barbara L Gracious, Barbara H Hanusa, Katherine L Wisner, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Intravenous pulse loading of clomipramine in adolescents with depression
F R Sallee, B G Pollock, J M Perel, et al.
Psychiatry Research
|
November 1, 1989
Clomipramine and EEG sleep in depression
D J Kupfer, C L Ehlers, B G Pollock, et al.
Journal of Autism and Developmental Disorders
|
March 1, 1979
Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome
S Castells, C Chakrabarti, B G Winsberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1973
Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation
P G Dayton, J M Perel, R F Cunningham, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 240) with videos related to
Sort By:
Page
of 24
Journal of Clinical Pharmacology
|
February 1, 1995
Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients
S K Gupta, R L Kunka, A Metz, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 1, 1982
Pharmacokinetics of psychotropic drugs: what can it tell us?
P D Hrdina, L J Hutchinson, Y D Lapierre, et al.
Circulation
|
November 1, 1979
The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations
E G Giardina, J T Bigger, A H Glassman, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
July 1, 1992
Psychobiological methodology
N D Ryan, S Iyengar, J M Perel, et al.
Psychopharmacology Bulletin
|
January 1, 1994
Metabolic and physiologic consequences of nortriptyline treatment in the elderly
B G Pollock, J M Perel, C F Paradis, et al.
The Journal of Clinical Psychiatry
|
March 16, 2005
Weight changes in postpartum women with remitted depression
Barbara L Gracious, Barbara H Hanusa, Katherine L Wisner, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Intravenous pulse loading of clomipramine in adolescents with depression
F R Sallee, B G Pollock, J M Perel, et al.
Psychiatry Research
|
November 1, 1989
Clomipramine and EEG sleep in depression
D J Kupfer, C L Ehlers, B G Pollock, et al.
Journal of Autism and Developmental Disorders
|
March 1, 1979
Effects of L-5-hydroxytryptophan on monoamine and amino acids turnover in the Lesch-Nyhan syndrome
S Castells, C Chakrabarti, B G Winsberg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 1, 1973
Studies of the fate of metabolites and analogs of probenecid. The significance of metabolic sites, especially lack of ring hydroxylation
P G Dayton, J M Perel, R F Cunningham, et al.
Page
of 24